Use of clinical next-generation sequencing to identify melanomas harboring SMARCB1 mutations

Journal of Cutaneous Pathology
David L StockmanMichael Tetzlaff

Abstract

SMARCB1 (INI1/BAF47/SNF5) encodes a part of a multiprotein complex that regulates gene expression through chromatin remodeling. SMARCB1 expression is lost or downregulated in multiple human tumors, including epithelioid sarcoma, meningioma and rhabdoid tumors of the brain, soft tissue and kidney. A 46-gene or 50-gene next-generation sequencing AmpliSeq Cancer Panel (Life Technologies; San Francisco, CA, USA) was applied to ∼1400 primary or metastatic melanoma tissues. We identified eight cases of melanoma harboring mutations in SMARCB1. Immunohistochemistry demonstrated preservation of SMARCB1 protein expression in all cases. SMARCB1 mutations occurred together with TP53 mutations in five of the eight cases, suggesting a functional relationship between these tumor suppressors in melanoma. Because single-base substitutions in SMARCB1 occur in a small subset of melanomas and do not affect SMARCB1 protein expression, such mutations would only be discovered by sequencing approaches. Our findings highlight the potential for next-generation sequencing platforms to identify mutations unexpected for melanoma that may contribute to its oncogenic potential. Though rare, the identification of SMARCB1 mutations adds to the growing literatu...Continue Reading

References

Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·A MorozovG V Kalpana
Nov 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·C W RobertsS H Orkin
Dec 5, 2000·Cancer Genetics and Cytogenetics·M YugeT Kinoshita
Feb 13, 2001·British Journal of Cancer·U SchmitzA von Deimling
Apr 21, 2001·Molecular and Cellular Biology·C J GuidiS N Jones
Jun 18, 2002·Nature·Helen DaviesP Andrew Futreal
Jul 26, 2002·Molecular and Cellular Biology·Zhi-Kai ZhangGanjam V Kalpana
Sep 6, 2002·Genomics·Koshi MimoriMasaki Mori
Sep 30, 2003·Molecular Pathology : MP·P RieskeP P Liberski
Feb 18, 2004·Nature Reviews. Cancer·Charles W M Roberts, Stuart H Orkin
Aug 6, 2004·The New England Journal of Medicine·Amy HollemanWilliam E Evans
Oct 19, 2004·Cancer Cell·Mathew J Garnett, Richard Marais
Jan 12, 2005·Cancer Genetics and Cytogenetics·Magdalena ZakrzewskaPiotr Rieske
May 19, 2005·Cancer Research·Piergiorgio ModenaGabriella Sozzi
Aug 16, 2005·Proceedings of the National Academy of Sciences of the United States of America·Mary TsikitisGanjam V Kalpana
Nov 23, 2005·Proceedings of the National Academy of Sciences of the United States of America·Michael S IsakoffCharles W M Roberts
Mar 20, 2008·Advances in Experimental Medicine and Biology·Ulrike Leiter, Claus Garbe
Aug 14, 2009·Molecular Carcinogenesis·Jessica DelBoveBernard E Weissman
Oct 8, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hanyang LinGang Li
Nov 17, 2009·Clinical Genetics·T J M HulsebosM B Delatycki
Nov 18, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles M BalchVernon K Sondak
Dec 17, 2009·BMC Cancer·Vinod DagarElizabeth M Algar
Oct 12, 2010·Journal of Medical Genetics·I ChristiaansT J M Hulsebos

❮ Previous
Next ❯

Citations

Nov 23, 2015·Molecular Cell·Sheng F CaiScott A Armstrong
Oct 18, 2016·Seminars in Diagnostic Pathology·Christine E Fuller
Feb 14, 2017·Experimental Dermatology·Joon Ho ShimDong-Youn Lee
Mar 14, 2019·The American Journal of Surgical Pathology·Inga-Marie SchaeferVickie Y Jo
Aug 16, 2018·EMBO Molecular Medicine·Johanna KondelinLauri A Aaltonen
Aug 7, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Priyadharsini NagarajanMichael T Tetzlaff
Jul 11, 2020·Seminars in Diagnostic Pathology·Inga-Marie Schaefer, Jason L Hornick
Feb 21, 2021·American Journal of Clinical Pathology·Inga-Marie SchaeferXiaohua Qian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Related Papers

Zhonghua wai ke za zhi [Chinese journal of surgery]
Yang Guo, Guang-lei Tian
Journal of the American Podiatric Medical Association
E F Meltzer, J S Nosanchuk
The American Journal of Surgical Pathology
Travis J Hollmann, Jason L Hornick
The American Journal of Surgical Pathology
D R Chase
© 2022 Meta ULC. All rights reserved